Only 8.3% of TNFR−/− chimeric mice developed papillomas, compared with 50% of control chimeras, and time of tumour onset was delayed in TNFR−/− chimeric mice (Fig. 2a). This evidence concerns the gene TNFRSF1A and papilloma.